Around one in 10 medical products in low, middle-income countries substandard or falsified: WHO

An estimated one in 10 medical products circulating in low and middle-income countries is either substandard or falsified.

PTI November 29, 2017 08:04:52 IST
Around one in 10 medical products in low, middle-income countries substandard or falsified: WHO

New Delhi: An estimated one in 10 medical products circulating in low and middle-income countries is either substandard or falsified, according to a new research from the World Health Organisation (WHO).

This means that people are taking medicines that fail to treat or prevent diseases. This not only leads to waste of money, but substandard or falsified medical products can cause serious illness or even death, a release by the WHO.

Around one in 10 medical products in low middleincome countries substandard or falsified WHO

Representational image. Getty Images

"Imagine a mother who gives up food or other basic needs to pay for her child's treatment, unaware that the medicines are substandard or falsified. Then, that treatment leads to her child's death," WHO Director-General Dr Tedros Adhanom Ghebreyesus said.

"This is unacceptable. Countries have agreed on measures at the global level. It is time to translate those into tangible actions," Dr Ghebreyesus said.

Since 2013, the WHO has received 1,500 reports of cases of substandard or falsified products. Of these, antimalarialsand antibiotics are the most commonly reported.

Most of the reports, around 42 percent, come from sub-Saharan Africa, 21 percent from the Americas and 21 percent from the European region, the WHO release said.

This is likely just a small fraction of the total problem and many cases may be going unreported, it said.

"Substandard or falsified medicines not only have a tragic impact on individual patients and their families, but also are a threat to antimicrobial resistance, adding to the worrying trend of medicines losing their power to treat," Dr Mariângela Simão, Assistant Director-General for Access to Medicines, Vaccines and Pharmaceuticals at the WHO said.

This study was based on more than 100 research papers on medicine quality surveys done in 88 low and middle-income countries involving 48,000 samples of medicines, the release said.

Lack of accurate data means that these estimates are just an indication of the scale of the problem, the WHO release said, adding more research is needed to more accurately estimate the threat posed by substandard and falsified medical products.

Updated Date:

also read

European Medicines Agency advises against use of Vaxzevria in people with history of capillary leak syndrome
India

European Medicines Agency advises against use of Vaxzevria in people with history of capillary leak syndrome

Capillary leak syndrome is an extremely rare but dangerous disorder in which fluid leaks from tiny blood arteries, causing edema or swelling mostly in the arms and legs, hypotension and blood thickening

IMA seeks removal of one-week provision for posting of medical interns in Ayush medicine
India

IMA seeks removal of one-week provision for posting of medical interns in Ayush medicine

The IMA warned that a week’s training in Indian systems of medicine as an elective will pave way for a ‘half-baked mixopath, which is disastrous for the country’

World Hepatitis Day 2021: Theme and significance of international holiday; WHO organises campaigns to raise awareness
World

World Hepatitis Day 2021: Theme and significance of international holiday; WHO organises campaigns to raise awareness

Viral hepatitis is considered a serious health condition, with its B and C strains claiming 1.1 million deaths every year